Summary of Classification and Labelling
Notified classification and labelling
General Information
EC / List no.
|
Name |
CAS Number
|
---|---|---|
200-171-3 | Methylprednisolone 21-acetate | 53-36-1 |
Notified classification and labelling according to CLP criteria
Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
---|---|---|---|---|---|---|---|---|---|---|---|
Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
Repr. 2 | H361 (H361d: Suspecte...) | H361 (H361d: Suspecte...) |
GHS08 Wng |
State/Form
|
2 | View details | |||||
STOT RE 2 | H373 (other:Not deter...) | H373 | |||||||||
Repr. 2 | H361 | H361 |
GHS08 Wng |
State/Form
|
40 | View details | |||||
Repr. 1A | H360 (Developmental) | H360 (developmental) |
GHS08 Dgr |
State/Form
|
29 | View details | |||||
STOT RE 2 | H373 (Adrenal gland) | H373 (Adrenal gland) | |||||||||
Repr. 2 | H361 | H361 (H361fd Suspecte...) |
GHS08 Wng |
1 | View details | ||||||
Repr. 1A | H360 | H360 |
GHS08 Dgr |
State/Form
|
1 | View details | |||||
STOT RE 2 | H373 (data lacking) | H373 | |||||||||
Repr. 1B | H360 (H360D May damag...) | H360 (H360D May damag...) |
GHS08 Dgr |
State/Form
|
1 | View details | |||||
STOT RE 2 | H373 (not known) | H373 | |||||||||
H302 |
GHS08 GHS07 Dgr |
1 | View details | ||||||||
H341 | |||||||||||
Repr. 2 | H361 (d) | H361 (d) |
GHS08 Wng |
State/Form
|
1 | View details | |||||
Repr. 2 | H361 (f) | H361 |
GHS08 Wng |
State/Form
|
1 | View details | |||||
STOT RE 2 | H373 (Endocrine syste...) | H373 | |||||||||
Repr. 2 | H361 (fd) | H361 |
GHS08 Dgr |
1 | View details | ||||||
STOT RE 1 | H372 (not specified) | H372 | |||||||||
Repr. 2 | H361 (H361:Suspected ...) | H361 (Suspected of da...) |
GHS08 Wng |
1 | View details |
Number of Aggregated Notifications: 11